Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thalidomide”

379 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 379 results

Testing effectiveness (Phase 2)Study completedNCT00226980
What this trial is testing

A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma

Who this might be right for
Kidney Neoplasms
Stanford University 30
Large-scale testing (Phase 3)Study completedNCT00657488
What this trial is testing

Thalidomide 100 mg/Day Versus Thalidomide 400 mg/Day in Relapse Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 400
Testing effectiveness (Phase 2)Study completedNCT00274820
What this trial is testing

Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+1 more
Case Comprehensive Cancer Center 15
Testing effectiveness (Phase 2)Study completedNCT00519688
What this trial is testing

UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
National Taiwan University Hospital 44
Testing effectiveness (Phase 2)Study completedNCT02410694
What this trial is testing

Ixazomib in Combination With Thalidomide - Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Arbeitsgemeinschaft medikamentoese Tumortherapie 90
Testing effectiveness (Phase 2)Study completedNCT00540007
What this trial is testing

Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Disease
Washington University School of Medicine 80
Testing effectiveness (Phase 2)Study completedNCT00165230
What this trial is testing

Thalidomide in Combination With Temodar in Patients With Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumor
Dana-Farber Cancer Institute 32
Large-scale testing (Phase 3)Study completedNCT00049673
What this trial is testing

Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
NCIC Clinical Trials Group 332
Large-scale testing (Phase 3)UnknownNCT01532856
What this trial is testing

Iberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 Years

Who this might be right for
Multiple Myeloma
Grupo de Estudos Multicentricos em Onco-Hematologia 64
Testing effectiveness (Phase 2)Study completedNCT00040937
What this trial is testing

S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
SWOG Cancer Research Network 147
Early research (Phase 1)Study completedNCT00258245
What this trial is testing

Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Barbara Ann Karmanos Cancer Institute 5
Testing effectiveness (Phase 2)Study completedNCT02507336
What this trial is testing

Long-Term Followup and/or Thalidomide Maintenance Therapy for Patients Enrolled on Clinical Trial 20030165

Who this might be right for
Mantle Cell LymphomaNon-Hodgkin's Lymphoma
University of Miami 2
Not applicableUnknownNCT03089411
What this trial is testing

Collection of Additional Data Followed the Study IFM 2013-04

Who this might be right for
Myeloma Multiple
Nantes University Hospital 340
Testing effectiveness (Phase 2)Study completedNCT00079092
What this trial is testing

Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Wake Forest University Health Sciences 18
Testing effectiveness (Phase 2)Study completedNCT00025467
What this trial is testing

Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Endometrial AdenoacanthomaEndometrial AdenocarcinomaEndometrial Adenosquamous Cell Carcinoma+3 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)UnknownNCT03184844
What this trial is testing

The Effective and Safety of Thalidomide in TI

Who this might be right for
Thalassemia
Xiao-Lin Yin 100
Early research (Phase 1)Study completedNCT00052416
What this trial is testing

Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Beth Israel Deaconess Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT01779167
What this trial is testing

Thalidomide, Lenalidomide, and Rituximab for Previously Treated Waldenstrom Macroglobulinemia

Who this might be right for
Waldenstrom Macroglobulinemia
Weill Medical College of Cornell University 4
Testing effectiveness (Phase 2)WithdrawnNCT00112879
What this trial is testing

Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma+1 more
The Cleveland Clinic
Testing effectiveness (Phase 2)Study completedNCT01632150
What this trial is testing

Safety Study of Elotuzumab in Combination With Thalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Relapsed and/or Refractory Multiple Myeloma
Bristol-Myers Squibb 51
Load More Results